BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33050567)

  • 1. The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells.
    Fahmy UA; Aldawsari HM; Badr-Eldin SM; Ahmed OAA; Alhakamy NA; Alsulimani HH; Caraci F; Caruso G
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33050567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells.
    Awan ZA; Fahmy UA; Badr-Eldin SM; Ibrahim TS; Asfour HZ; Al-Rabia MW; Alfarsi A; Alhakamy NA; Abdulaal WH; Al Sadoun H; Helmi N; Noor AO; Caraci F; Almasri DM; Caruso G
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32604984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.
    Kataoka H; Yang K; Rock KL
    Eur J Pharmacol; 2015 Jan; 746():174-9. PubMed ID: 25449036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells.
    Alfaifi MY; Shati AA; Elbehairi SEI; Fahmy UA; Alhakamy NA; Md S
    3 Biotech; 2020 Mar; 10(3):133. PubMed ID: 32154046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin-Loaded Emulsomes Exhibit Improved Cytotoxic and Apoptosis in Prostate Cancer Cells.
    Alhakamy NA; Badr-Eldin SM; Aldawsari HM; Alfarsi A; Neamatallah T; Okbazghi SZ; Fahmy UA; Ahmad OAA; Eid BG; Mahdi WA; Alghaith AF; Alshehri S; Md S
    AAPS PharmSciTech; 2021 Jun; 22(5):177. PubMed ID: 34128106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation.
    Alhakamy NA; Fahmy UA
    Biomed Pharmacother; 2022 Oct; 154():113619. PubMed ID: 36081285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout.
    Steinberg AS; Vince BD; Choi YJ; Martin RL; McWherter CA; Boudes PF
    J Rheumatol; 2017 Mar; 44(3):374-379. PubMed ID: 27980008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment.
    Aldawsari HM; Ahmed OAA; Alhakamy NA; Neamatallah T; Fahmy UA; Badr-Eldin SM
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34073780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System.
    Al-Amodi YA; Hosny KM; Alharbi WS; Safo MK; El-Say KM
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32531910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piceatannol-Loaded Emulsomes Exhibit Enhanced Cytostatic and Apoptotic Activities in Colon Cancer Cells.
    Alhakamy NA; Badr-Eldin SM; Ahmed OAA; Asfour HZ; Aldawsari HM; Algandaby MM; Eid BG; Abdel-Naim AB; Awan ZA; Alghaith AF; Alaofi AL; Mohamed AI; Okbazghi SZ; Al-Rabia MW; Fahmy UA
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32414040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febuxostat solubilization and stabilization approach using solid dispersion method: Synergistic effect of dicalcium phosphate dehydrate and chitosan.
    Sohn JS; Choi JS
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127266. PubMed ID: 37802445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates.
    Badr-Eldin SM; Alhakamy NA; Fahmy UA; Ahmed OAA; Asfour HZ; Althagafi AA; Aldawsari HM; Rizg WY; Mahdi WA; Alghaith AF; Alshehri S; Caraci F; Caruso G
    Front Pharmacol; 2020; 11():642171. PubMed ID: 33633571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an optimized febuxostat self-nanoemulsified loaded transdermal film:
    Alhakamy NA; Fahmy UA; Ahmed OAA; Almohammadi EA; Alotaibi SA; Aljohani RA; Alharbi WS; Alfaleh MA; Alfaifi MY
    Pharm Dev Technol; 2020 Mar; 25(3):326-331. PubMed ID: 31794286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of atorvastatin emulsomes as a topical antifungal agent.
    Eita AS; M A Makky A; Anter A; Khalil IA
    Drug Deliv; 2022 Dec; 29(1):3414-3431. PubMed ID: 36428290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative HPTLC method with fluorescence detection for assessment of febuxostat-montelukast combination and study of their protective effects against gouty arthritis.
    Hosny NM; Atia NN; El-Gizawy SM; Badary DM; Hareedy MS
    Analyst; 2018 Sep; 143(18):4366-4378. PubMed ID: 30113041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioprotective Effect of Febuxostat Against Testicular Damage Induced by Ionizing Radiation in Mice.
    Amiri FT; Raeispour M; Farzipour S; Hosseinimehr SJ
    Curr Radiopharm; 2022; 15(2):134-140. PubMed ID: 34488603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia.
    Oh SH; Choi SY; Choi HJ; Ryu HM; Kim YJ; Jung HY; Cho JH; Kim CD; Park SH; Kwon TH; Kim YL
    FASEB J; 2019 Jun; 33(6):7301-7314. PubMed ID: 30860872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Pharmacokinetic Feasibility of Febuxostat/L-pyroglutamic Acid Cocrystals in Rats and Mice.
    Yu JE; You BH; Bae M; Han SY; Jung K; Choi YH
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase contributes to sustained airway epithelial oxidative stress after scald burn.
    Jacob S; Herndon DN; Hawkins HK; Enkhbaatar P; Cox RA
    Int J Burns Trauma; 2017; 7(6):98-106. PubMed ID: 29119062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
    Ernst ME; Fravel MA
    Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.